BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38465981)

  • 21. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast Activation Protein-Targeted PET/CT with
    Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
    J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of [
    Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
    Zhang Z; Cheng C; Jiang H; Pan G; Yu Y; Jin G; Zuo C
    Clin Nucl Med; 2024 May; 49(5):409-418. PubMed ID: 38465929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-Head Comparison of
    Promteangtrong C; Siripongsatian D; Jantarato A; Kunawudhi A; Kiatkittikul P; Yaset S; Boonkawin N; Chotipanich C
    J Nucl Med; 2022 Aug; 63(8):1155-1161. PubMed ID: 34857655
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of [
    Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 68 Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies.
    Zheng W; Liu L; Feng Y; Wang L; Chen Y
    Nucl Med Commun; 2023 Mar; 44(3):194-203. PubMed ID: 36472415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior Tumor Detection for
    Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
    J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial Evaluation of [
    Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
    J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of [
    Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [
    Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Luo Y; Pan Q; Zhou Z; Li M; Wei Y; Jiang X; Yang H; Li F
    Radiology; 2023 May; 307(3):e222052. PubMed ID: 36853178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68Ga-FAPI PET/CT in Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy.
    Fu H; Fu J; Huang J; Su X; Chen H
    Clin Nucl Med; 2021 May; 46(5):427-430. PubMed ID: 33661204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical prospective study of Gallium 68 (
    Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.